Full-Time

Director – Biostatistics

Updated on 1/15/2025

Vir Biotechnology

Vir Biotechnology

501-1,000 employees

Develops monoclonal antibodies for infectious diseases

AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

$203.5k - $284kAnnually

+ Bonus + Equity

Expert

No H1B Sponsorship

San Francisco, CA, USA

Requires onsite presence in San Francisco for four days per week.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
R
Requirements
  • PhD. in Biostatistics and 10+ years of relevant work experience, or M.S. in Biostatistics and 13+ years of relevant work experience
  • Hands-on Experience in INDs, NDAs, MAAs, or other regulatory submissions
  • In-depth knowledge of statistical methods for clinical trials
  • Knowledge of FDA, EMA, and ICH regulations and guidelines
  • Proficient in statistical programming (SAS and R)
  • Experience leading statistical efforts for multiple studies
  • Fluent in data standards, including SDTM and ADaM
  • Experience with outsourced statistical services provided by CROs
Responsibilities
  • As a biostatistics expert for VIR clinical programs you will provide strategic input to optimize trial designs in late phase registrational studies
  • You will work with internal and external statistical programming team members on the planning and execution of statistical deliverables
  • Conduct statistical simulations to ensure robust and efficient statistical designs and address identified or potential statistical issues arising with studies
  • Contribute to clinical protocol development, including authoring or review of the Statistics section and reviewing of other sections by applying statistical principles
  • Author or review the development of statistical analysis plans for clinical trials and oversee the development of tables, figures, and listings, and associated deliverables
  • Review electronic case report form (eCRF) designs to ensure data collection meets the requirements of statistical analyses
  • Perform QC/QA of statistical deliverables including validation of main analysis results
  • Contribute to clinical study reports, including authoring of statistical methods, and interpretation of study results
  • Accountable for assigned statistical activities to support IND/NDA/MAA or other regulatory submissions; provide review for required components of regulatory submissions including appropriate datasets, define files, reviewer's guides, and other relevant documents
  • Address statistical questions/comments from FDA and other regulatory agencies, or IRB/ECs
  • Lead standardization and process improvement efforts for Biostatistics function, and contribute to cross-functional process improvement efforts including the definition of biostatics templates and standards
  • Represent VIR regarding statistical issues in meetings with external parties including regulatory agencies and corporate partners
  • Support inspection readiness activities

Vir Biotechnology develops treatments for infectious diseases by leveraging the immune system. They use a platform that combines monoclonal antibodies with machine learning to create a database of human antibodies, which helps in designing effective medicines. Their projects include therapies for hepatitis B, HIV, and COVID-19, as well as a T cell vaccine for HIV prevention. Vir stands out by integrating AI in drug development, aiming to transform lives through innovative treatments.

Company Stage

IPO

Total Funding

$640.6M

Headquarters

San Francisco, California

Founded

2016

Growth & Insights
Headcount

6 month growth

5%

1 year growth

3%

2 year growth

6%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased interest in AI-driven drug discovery benefits Vir's AI capabilities.
  • The rise of personalized medicine aligns with Vir's monoclonal antibody focus.
  • Global pandemic preparedness funding supports Vir's broad-spectrum antiviral therapies.

What critics are saying

  • Leadership instability due to key executive resignations may disrupt operations.
  • Job cuts and facility closures indicate potential financial strain.
  • Struggles to diversify beyond COVID-19 antibody success may impact revenue growth.

What makes Vir Biotechnology unique

  • Vir Biotechnology uses AI-enhanced capabilities for monoclonal antibody development.
  • The company focuses on immune system manipulation for targeted therapies.
  • Vir's pipeline includes a potential functional cure for chronic hepatitis B.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Comprehensive healthcare coverage

Employer matched 401(k)

Employee stock purchase plan

Childcare assistance

Tuition reimbursement